2011 Regular Session

SENATE BILL 485

File Code: Taxes - Income Crossfiled with: HOUSE BILL 587
Sponsored By:
Senators King, DeGrange, Madaleno, Manno, and Young
Entitled:
Biotechnology Investment Tax Credit - Qualified Maryland Biotechnology Company

Synopsis:

Altering the definition of "qualified Maryland biotechnology company" for purposes of the biotechnology investment tax credit for fiscal years 2012 and 2013 only, to allow investments in companies that have been in active business for up to 15 years to qualify for the credit; etc.

History by Legislative and Calendar Date

Legislative date is used to record history occurring in the Chambers otherwise Calendar date is used.
Senate Action
2/4
First Reading Budget and Taxation
2/16
Hearing 3/9 at 1:00 p.m.
3/10
Hearing 3/10 at 1:00 p.m.
3/16

Favorable with Amendments Report by Budget and Taxation
3/17
Favorable with Amendments Report Adopted
Second Reading Passed with Amendments
3/21
Third Reading Passed (47-0)
House Action
3/20
First Reading Ways and Means
3/30
Hearing 4/1 at 1:00 p.m.

Sponsored by:

Senator Nancy J. King, District 39
Senator James E. DeGrange, Sr., District 32
Senator Richard S. Madaleno, Jr., District 18
Senator Roger P. Manno, District 19
Senator Ronald N. Young, District 3

Bill indexed under the following Subjects:

Business and Economic Development, Department of
Income Tax
Industry and Technology
Investments -see also- Securities
Medical Research
Small Business
Tax Credits -see also- Circuit Breaker

Bill affects the following Statutes:

Tax - General
( 10-725 , 10-725 )

Documents

All documents except Roll Call Votes are displayed in PDF format:
Bill Text: First Reading, Third Reading, Enrolled
Fiscal and Policy Note: Available
Amendments:
Senate
Number: 729437/01     Offered on: March 17, 2011   at: 10:39 a.m.     Status: Adopted
Committee Votes :
Senate
Budget and Taxation
Roll Call Vote (Legislative date is shown):
Senate
March 21, 2011: Third Reading Passed (47-0)